ca-ssis
ca-ssis / iStockphoto.com
16 January 2019Americas

FDA announces new measures to boost gene therapy innovation

The US Food and Drug Administration (FDA) has announced new policies to advance the development of safe and effective cell and gene therapies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.

More on this story

Biotechnology
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.

More on this story

Biotechnology
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019   A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.